Organon & Co. (OGN)

Jun 2, 2025, 3:59 PM EDT - 19 hours ago

Shareholders who lost money on Organon & Co. (NYSE: OGN) Should Contact Wolf Haldenstein

May 31, 2025, 7:10 AM EDT - 3 days ago

OGN CLASS NOTICE: Organon & Co. Investors may have been Affected by Fraud – Contact BFA Law before July 22 Court Deadline (NYSE:OGN)

May 30, 2025, 11:50 AM EDT - 3 days ago

Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein

May 29, 2025, 6:30 AM EDT - 5 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Organon Lawsuit - OGN

May 27, 2025, 12:23 PM EDT - 6 days ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Organon & Co. (OGN)

May 27, 2025, 7:30 AM EDT - 7 days ago

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection

May 25, 2025, 8:49 AM EDT - 9 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

May 21, 2025, 10:00 AM EDT - 13 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Shareholders to Connect

May 20, 2025, 10:00 AM EDT - 14 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Organon & Co. (OGN) And Encourages Shareholders to Reach Out

May 20, 2025, 5:35 AM EDT - 14 days ago

OGN INVESTIGATION: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Firm

May 19, 2025, 10:00 AM EDT - 15 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Shareholders to Learn More About the Investigation

May 18, 2025, 10:00 AM EDT - 16 days ago

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 16, 2025, 10:00 AM EDT - 18 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Investors to Learn More About the Investigation

May 15, 2025, 10:00 AM EDT - 19 days ago

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 14, 2025, 10:00 AM EDT - 20 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Investors to Connect

May 13, 2025, 10:00 AM EDT - 21 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Stockholders to Inquire about Securities Investigation

May 12, 2025, 11:47 AM EDT - 21 days ago

Organon & Co: Cost Takeout Catalysts, Initiate Strong Buy

May 11, 2025, 10:00 AM EDT - 23 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Stockholders to Connect

May 9, 2025, 10:00 AM EDT - 25 days ago

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 8, 2025, 11:08 AM EDT - 26 days ago

Organon: Management Slashes Dividend - This Feels Disastrous

May 8, 2025, 10:16 AM EDT - 26 days ago

EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug

GSK

May 8, 2025, 10:00 AM EDT - 26 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation